SPC80
Pónatíníb, á öllum formum svo sem sölt, lausnarsambönd eða vatnssambönd þess
Status:
VeittApplication date:
12.12.2013Application published:
15.1.2014Grant published:
15.7.2015
Max expiry date:
2.7.2028Next due date:
31.12.2026Medicine name:
IclusigMedicine for children:
No
Timeline
Today
12.12.2013Application
15.1.2014Publication
15.7.2015Registration
2.7.2028Expires
Marketing license
IS authorization number:
EU/1/13/839/001-002; EU/1/13/839/003-004Date:
19.7.2013
Foreign authorization number:
EU/1/13/839Date:
1.7.2013
Owner
Name:
Takeda Pharmaceuticals U.S.A., Inc.Address:
500 Kendall Street, Cambridge US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1973545